Top Markets
#1 Bitcoin Cash Bitcoin Cash +34.44%
#2 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +34.19%
#3 Fabric Protocol Fabric Protocol +31.59%
#4 Audiera Audiera +30.77%
#5 Tutorial Tutorial +29.53%
#6 GALA GALA +27.47%
#7 Arowana Arowana +27.09%
#8 Ethena Staked ENA Ethena Staked ENA +26.36%
#9 Useless Coin Useless Coin +25.58%
#10 aPriori aPriori +24.99%
Coin of the day
Bitcoin Cash Bitcoin Cash
Settings
Language
ENGLISH
Currency
USD
Theme
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Rank in Stocks #24449
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Share Price
$0.78611575
Market Cap
$60.45M
Change (1 day)
0.00%
Change (1 year)
-12.06%
Country
NO
Trade Lytix Biopharma AS (LYTIX)

Category

Healthcare
EPS for Lytix Biopharma AS (LYTIX)
EPS as of 2026 TTM: 0
According to Lytix Biopharma AS latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Lytix Biopharma AS from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH